Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04115293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: zilucoplan (RA101495)
DRUG: Placebo

Sponsor

Ra Pharmaceuticals, Inc.